Get the Weekly Intelligence Brief — top committee picks every Sunday.
JBS · NYSE · STOCK

Jbs N.V.

Consumer Defensive Updated August 11, 2026
$13.03
52W $11.49 – $18.65
61/100
$28.88B
18.0
0.16
AI Committee Verdict
Buy
61/100
Conviction: Contested · 67% agreement · 6 analysts
Contested

Is JBS Bullish or Bearish?

Bullish. Innellis AI committee rates Jbs N.V. (JBS) Buy with a composite score of 61/100 , based on 6 analysts with 67% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +14.16 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -5.84 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 48.5% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 2.65) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • P/E of 8.2 is inexpensive for the broad market — Value
  • ROE of 20.5% shows genuine earnings power backing the valuation — Value
  • Dividend yield of 14.9% pays you to wait — Value
  • Revenue growing 48.5% YoY -- genuine top-line momentum — Growth
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Debt-to-equity of 2.65 adds balance-sheet risk to the value case — Value
  • MACD histogram negative -- bearish momentum — Technical
  • High leverage (debt-to-equity 2.65) amplifies downside in a stress scenario — Risk
  • Bollinger bandwidth of 27.8% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
61/100
Agreement
67%
Analysts
6
Conviction
Contested
Sector Rank
Top 31%
of 72 Consumer Defensive peers
Value Analyst bullish
61 / 100 · High confidence
Classic value case: cheap on multiples with earnings power to back it up
+ P/E of 8.2 is inexpensive for the broad market
− Debt-to-equity of 2.65 adds balance-sheet risk to the value case
Growth Analyst bullish
85 / 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 48.5% YoY -- genuine top-line momentum
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst bearish
32 / 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 2.65) amplifies downside in a stress scenario
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst bullish
60 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
41.6
Neutral
MACD Histogram
-0.009
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$12.87
Resistance
$15.15
Bollinger %B
0.48
Inside Bands
Price vs Moving Averages
EMA 9
$13.53 Below
EMA 21
$13.21 Below
EMA 50
$13.13 Below
EMA 200
$14.12 Below

Fundamental Analysis

Valuation
63
Profitability
38
Financial Health
72
Cash Flow
70
Valuation
P/E Ratio 18.0×
P/B Ratio
PEG Ratio -0.47
Dividend Yield 7.68%
52W High $18.65
52W Low $11.49
Quality & Growth
ROE 2318.3%
ROA 446.8%
Gross Margin 1185.7%
Operating Margin 384.4%
Revenue Growth YoY
Debt / Equity 0.00
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 18.0 (inexpensive relative to a 15-40x range); Price-to-book of 1732.6x; PEG ratio of -0.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 23.2%; Return on assets of 4.5%; Net margin of 1.7%; Gross margin of 11.9%; Current ratio of 1.33 (tight short-term liquidity); Debt-to-equity of 0.00; Free cash flow per share is positive (2.24); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full JBS Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore JBS Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime